Exact Mass: 353.0949

Exact Mass Matches: 353.0949

Found 57 metabolites which its exact mass value is equals to given mass value 353.0949, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Rugosinone

1,3-Dioxolo[4,5-g]isoquinolin-5-yl(2-hydroxy-3,4-dimethoxyphenyl)methanone

C19H15NO6 (353.0899)


   

4-[(4'-O-Acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

(2S,3R,4S,5R,6S)-4,5-dihydroxy-6-[4-(isothiocyanatomethyl)phenoxy]-2-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


4-[(4-O-Acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate is a glucosinolate that has been isolated from the seeds and leaves of Moringa oleifera (horseradish tree) and the seeds of Moringa peregrina. It is also found in herbs and spices. Constituent of seeds of Moringa oleifera (horseradish tree) and Moringa peregrina. 4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside is found in herbs and spices.

   

Acenocoumarol

4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one

C19H15NO6 (353.0899)


Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, XI and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients on acenocoumarol are prohibited from giving blood. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

3,4-Dioxosarcocapnidine

3,4-Dioxosarcocapnidine

C19H15NO6 (353.0899)


   

9-Methoxyaristolactam IV

9-Methoxyaristolactam IV

C19H15NO6 (353.0899)


   

[4-(3-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

[4-(3-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

C16H19NO6S (353.0933)


   

7,8,10-Trimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

7,8,10-Trimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

C19H15NO6 (353.0899)


   

2,3:9,10-Bis(methylenedioxy)-5,6-dihydro-8H-dibenzo[a,g]quinolizine-1,8-diol

2,3:9,10-Bis(methylenedioxy)-5,6-dihydro-8H-dibenzo[a,g]quinolizine-1,8-diol

C19H15NO6 (353.0899)


   

[4-(2-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

[4-(2-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

C16H19NO6S (353.0933)


   

(+/-)-linaresine|(??)-Linaresine|8,9-dimethoxy-6,7-methylenedioxy-12H<1>benzoxepino<2,3,4-ij>isoquinolin-12-ol|linaresinen

(+/-)-linaresine|(??)-Linaresine|8,9-dimethoxy-6,7-methylenedioxy-12H<1>benzoxepino<2,3,4-ij>isoquinolin-12-ol|linaresinen

C19H15NO6 (353.0899)


   

7-methoxy-aristololactam IV

7-methoxy-aristololactam IV

C19H15NO6 (353.0899)


   

adlumidine|bicucculine|D-bicucculine

adlumidine|bicucculine|D-bicucculine

C19H15NO6 (353.0899)


   

dichotomide V

dichotomide V

C18H15N3O5 (353.1012)


A beta-carboline alkaloid isolated from Stellaria dichotoma var. lanceolata.

   

(S)-Acenocoumarol

4-hydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one

C19H15NO6 (353.0899)


The (R)-enantiomer of acenocoumarol. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists A hydroxycoumarin that is warfarin in which the hydrogen at position 4 of the phenyl substituent is replaced by a nitro group. D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

Cyclopenta[c]pyrrole, benzoic acid deriv

Cyclopenta[c]pyrrole, benzoic acid deriv

C15H19N3O5S (353.1045)


   

4-Hydroxybenzyl isothiocyanate 4''-acetylrhamnoside

4,5-dihydroxy-6-[4-(isothiocyanatomethyl)phenoxy]-2-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide

C14H16ClN5O4 (353.0891)


   

n-bsmoc-l-leucine

n-bsmoc-l-leucine

C16H19NO6S (353.0933)


   

n-bsmoc-l-isoleucine

n-bsmoc-l-isoleucine

C16H19NO6S (353.0933)


   

Side chain for meropenem

Side chain for meropenem

C15H19N3O5S (353.1045)


   

4-[(3,3-Dimethylbutanoyl)amino]-3,5-difluoro-N-(1,3-thiazol-2-yl) benzamide

4-[(3,3-Dimethylbutanoyl)amino]-3,5-difluoro-N-(1,3-thiazol-2-yl) benzamide

C16H17F2N3O2S (353.1009)


   

ethyl 2-piperazine-4-(2,5-difluoro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(2,5-difluoro)phenyl thiazole-5-carboxylate

C16H17F2N3O2S (353.1009)


   

1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione

1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione

C15H19N3O5S (353.1045)


   

4-[6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid

4-[6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid

C16H20ClN3O2S (353.0965)


   

AcenocouMarol-d4

AcenocouMarol-d4

C19H15NO6 (353.0899)


   

3-(4-ACETOXY-PHENYL)-2-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

3-(4-ACETOXY-PHENYL)-2-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

C19H15NO6 (353.0899)


   

3,6-Diamino-5-cyano-4-(4-ethoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide

3,6-Diamino-5-cyano-4-(4-ethoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide

C17H15N5O2S (353.0946)


   

6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine

6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine

C19H16FN3OS (353.0998)


   

(S)-2-amino-4-(4-((3,4-dichlorobenzyl)oxy)phenyl)-2-methylbutan-1-ol

(S)-2-amino-4-(4-((3,4-dichlorobenzyl)oxy)phenyl)-2-methylbutan-1-ol

C18H21Cl2NO2 (353.0949)


P053 is a potent, non-competitive and selective ceramide synthase 1 (CerS1) inhibitor wirh an IC50 of 0.5?μM. P053 acts as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle. Whole-body adiposity regulator[1].

   

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-1,3-oxazole-4-carbonitrile

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-1,3-oxazole-4-carbonitrile

C19H16ClN3O2 (353.0931)


   

2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C19H16ClN3O2 (353.0931)


   

Chlorogenate anion

Chlorogenate anion

C16H17O9- (353.0873)


   

3-(2,4-Dihydroxyphenyl)-7-hydroxy-6-(3-methylbut-2-enyl)-4-oxochromen-5-olate

3-(2,4-Dihydroxyphenyl)-7-hydroxy-6-(3-methylbut-2-enyl)-4-oxochromen-5-olate

C20H17O6- (353.1025)


   

3-Prenyl-5,7,2,4-tetrahydroxyisoflavone

3-Prenyl-5,7,2,4-tetrahydroxyisoflavone

C20H17O6- (353.1025)


   

3-(2,4-Dihydroxyphenyl)-5-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-7-olate

3-(2,4-Dihydroxyphenyl)-5-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-7-olate

C20H17O6- (353.1025)


   

N-Acetyl-S-(2,6,7-trimethyl-3,5-dioxo-3H,5H-pyrazolo[1,2-a]pyrazol-1-ylmethyl)-L-cysteine

N-Acetyl-S-(2,6,7-trimethyl-3,5-dioxo-3H,5H-pyrazolo[1,2-a]pyrazol-1-ylmethyl)-L-cysteine

C15H19N3O5S (353.1045)


   

trans-5-O-caffeoyl-D-quinate

trans-5-O-caffeoyl-D-quinate

C16H17O9- (353.0873)


A hydroxy monocarboxylic acid anion that is the conjugate base of trans-5-O-caffeoyl-D-quinic acid; major species at pH 7.3.

   

1-[[2-(4-Chlorophenyl)-1-oxoethyl]amino]-3-(1-naphthalenyl)urea

1-[[2-(4-Chlorophenyl)-1-oxoethyl]amino]-3-(1-naphthalenyl)urea

C19H16ClN3O2 (353.0931)


   

1-[1-(3-Chloro-4-fluorophenyl)-2,5-dioxo-3-pyrrolidinyl]-4-piperidinecarboxamide

1-[1-(3-Chloro-4-fluorophenyl)-2,5-dioxo-3-pyrrolidinyl]-4-piperidinecarboxamide

C16H17ClFN3O3 (353.0942)


   

1-(1-Azepanyl)-2-(2-bromo-4-propan-2-ylphenoxy)ethanone

1-(1-Azepanyl)-2-(2-bromo-4-propan-2-ylphenoxy)ethanone

C17H24BrNO2 (353.099)


   

4-Methoxybenzoic acid [2-oxo-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]ethyl] ester

4-Methoxybenzoic acid [2-oxo-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]ethyl] ester

C18H15N3O5 (353.1012)


   

(2S)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]-2-phenylacetamide

(2S)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]-2-phenylacetamide

C19H16ClN3O2 (353.0931)


   

4H,5H-3-Methoxycarbonyl-4-(1-methoxycarbonylpyrrol-2-YL)methylene-1-phenylpyrazol-5-one

4H,5H-3-Methoxycarbonyl-4-(1-methoxycarbonylpyrrol-2-YL)methylene-1-phenylpyrazol-5-one

C18H15N3O5 (353.1012)


   

4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside

4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside

C16H19NO6S (353.0933)


   

Chlorogenate

Chlorogenate

C16H17O9 (353.0873)


A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3.

   
   

(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

(10s)-10-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

(10s)-10-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

C19H15NO6 (353.0899)


   

3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

C16H19NO6S (353.0933)


   

12,14,16-trimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

12,14,16-trimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C19H15NO6 (353.0899)


   

methyl 3-({1-acetyl-8-hydroxy-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl 3-({1-acetyl-8-hydroxy-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H15N3O5 (353.1012)


   

(14r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

(14r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

C19H15NO6 (353.0899)


   

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

C16H19NO6S (353.0933)


   

10-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

10-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

C19H15NO6 (353.0899)


   

4-hydroxy-5,17-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,9,14(18),15-heptaene-12,13-dione

4-hydroxy-5,17-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,9,14(18),15-heptaene-12,13-dione

C19H15NO6 (353.0899)


   

4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

C19H15NO6 (353.0899)